- Home
- SNSE vs SINT Comparison
SNSE vs SINT Comparison
Compare SNSE & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNSE | SINT |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 11.7M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SNSE | SINT |
|---|---|---|
| Price | $29.28 | $2.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $72.50 | $16.00 |
| AVG Volume (30 Days) | ★ 572.3K | 30.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,887,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.90 |
| 52 Week Low | $0.25 | $1.72 |
| 52 Week High | $36.76 | $6.78 |
Technical Indicators
Market Signals| Indicator | SNSE | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 72.36 | 36.09 |
| Support Level | $7.94 | $2.55 |
| Resistance Level | $36.76 | $2.94 |
| Average True Range (ATR) | 4.19 | 0.16 |
| MACD | 0.64 | 0.00 |
| Stochastic Oscillator | 78.05 | 22.70 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.